ACE2 and pulmonary hypertension: Previously, a comparative study by Yamazato et al. [44] found that lentiviral vector-containing ACE2 treatment attenuated monocrotaline (MCT)-induced pulmonary hypertension with a reduction in pro-inflammatory cytokines in MCT-exposed mice.